|
ANKRD44 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.5507999995279E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.21390000010713E-07 |
| Normal-vs-Stage2 |
4.363200E-03 |
| Normal-vs-Stage3 |
2.066300E-02 |
| Normal-vs-Stage4 |
2.946400E-02 |
| Stage1-vs-Stage2 |
6.475400E-01 |
| Stage1-vs-Stage3 |
2.506400E-01 |
| Stage1-vs-Stage4 |
4.541600E-01 |
| Stage2-vs-Stage3 |
2.675000E-01 |
| Stage2-vs-Stage4 |
3.942800E-01 |
| Stage3-vs-Stage4 |
8.351400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.42530000030372E-07 |
| Normal-vs-AfricanAmerican |
1.123240E-01 |
| Normal-vs-Asian |
3.895900E-02 |
| Caucasian-vs-AfricanAmerican |
3.860200E-01 |
| Caucasian-vs-Asian |
1.190110E-02 |
| AfricanAmerican-vs-Asian |
8.101200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.35160000003243E-06 |
| Normal-vs-Female |
1.562640E-04 |
| Male-vs-Female |
6.012800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.532200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.08609999993625E-07 |
| Normal-vs-Age(61-80Yrs) |
3.571300E-04 |
| Normal-vs-Age(81-100Yrs) |
3.548800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.617960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.628000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.033600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.799020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.236600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.001400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.963710E-02 |
| Normal-vs-Grade 2 |
6.42719999999208E-05 |
| Normal-vs-Grade 3 |
5.78629999999913E-05 |
| Normal-vs-Grade 4 |
1.338040E-02 |
| Grade 1-vs-Grade 2 |
3.238000E-01 |
| Grade 1-vs-Grade 3 |
4.293200E-01 |
| Grade 1-vs-Grade 4 |
5.489200E-01 |
| Grade 2-vs-Grade 3 |
7.200200E-01 |
| Grade 2-vs-Grade 4 |
7.289000E-01 |
| Grade 3-vs-Grade 4 |
8.957200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.05300000003061E-06 |
| Normal-vs-ccB subtype |
5.79269999999577E-05 |
| ccA subtype-vs-ccB subtype |
6.808400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.01120000001376E-06 |
| Normal-vs-N1 |
1.266820E-01 |
| N0-vs-N1 |
4.895000E-01 |
|
|
